ELECTROCONVULSIVE STIMULI AND BRAIN PEPTIDES - EFFECT OF MODIFICATION OF SEIZURE DURATION ON NEUROPEPTIDE-Y, NEUROKININ-A, SUBSTANCE-P AND NEUROTENSIN

被引:38
作者
STENFORS, C [1 ]
SRINIVASAN, GR [1 ]
THEODORSSON, E [1 ]
MATHE, AA [1 ]
机构
[1] KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PSYCHIAT,S-11281 STOCKHOLM,SWEDEN
关键词
ELECTROCONVULSIVE STIMULUS; EICOSANOID SYNTHESIS INHIBITOR; DIAZEPAM; NEUROPEPTIDE-Y; NEUROTENSIN; RAT BRAIN; SEIZURE DURATION; TACHYKININ;
D O I
10.1016/0006-8993(92)91555-S
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied the effects of modification of duration of seizures induced by electroconvulsive stimuli (ECS) on the changes in concentration of neuropeptide Y (NPY), neurokinin A (NKA), substance P (SP) and neurotensin (NT)-like immunoreactivity (-LI) in specific rat brain regions. Rats were divided into groups pretreated with saline, indomethacin, flurbiprofen or diazepam prior to either six sham ECSs or six ECSs. After sacrifice by focused microwave irradiation, brains were dissected into frontal cortex, occipital cortex, striatum, hippocampus, pituitary and hypothalamic sections. Peptides were extracted and measured in extract aliquots by specific radioimmunoassays. Repeated ECS increased NPY-LI and NKA-LI in the hippocampus and the occipital cortex. No effect on SP-LI or NT-LI was found. Indomethacin and flurbiprofen had no effect on the tonic seizure time following ECS, and they did not affect the ECS-induced alterations of the brain peptides. Diazepam pretreatment decreased the tonic seizure time following ECS in a dose-dependent manner. However, diazepam did not modify the ECS-induced increase in NPY-LI and NKA-LI concentrations. The results firmly establish that ECS leads to specific peptide increases in discrete rat brain regions and raise the possibility that such changes may not entirely be a consequence of seizures per se.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 41 条
[1]   REGIONAL DISTRIBUTION OF ARACHIDONIC-ACID METABOLITES IN RAT-BRAIN FOLLOWING CONVULSIVE STIMULI [J].
BERCHTOLDKANZ, E ;
ANHUT, H ;
HELDT, R ;
NEUFANG, B ;
HERTTING, G .
PROSTAGLANDINS, 1981, 22 (01) :65-79
[2]   TACHYKININ MULTIPLICITY IN RAT CENTRAL-NERVOUS-SYSTEM AS STUDIED USING ANTISERA RAISED AGAINST SUBSTANCE-P AND NEUROKININ-A [J].
BRODIN, E ;
LINDEFORS, N ;
DALSGAARD, CJ ;
THEODORSSONNORHEIM, E ;
ROSELL, S .
REGULATORY PEPTIDES, 1986, 13 (3-4) :253-272
[3]  
DEVANAND DP, 1990, BIOL BASIS PSYCHIATR, V3, P170
[4]  
FINK M, 1990, NEUROPSYCHOPHARMACOL, V3, P73
[5]   POTENTIAL ANTICONVULSIVE PROPERTIES OF ENDOGENOUS PROSTAGLANDINS FORMED IN MOUSE-BRAIN [J].
FORSTERMANN, U ;
HELDT, R ;
KNAPPEN, F ;
HERTTING, G .
BRAIN RESEARCH, 1982, 240 (02) :303-310
[6]   REGIONAL STUDIES OF CATECHOLAMINES IN RAT BRAIN .I. DISPOSITION OF [3H]NOREPINEPHRINE [3H]DOPAMINE AND [3H]DOPA IN VARIOUS REGIONS OF BRAIN [J].
GLOWINSKI, J ;
IVERSEN, LL .
JOURNAL OF NEUROCHEMISTRY, 1966, 13 (08) :655-+
[7]  
HEILIG M, 1988, EUR J PHARMACOL, V47, P465
[8]  
HOFFMANN O, 1990, PHARMACOTHERAPIES PS, V3, P480
[9]  
KIMURA S, 1985, SUBSTANCE P METABOLI, P33
[10]   PROPOSALS FOR THE MECHANISM OF ACTION OF CONVULSIVE THERAPY - A SYNTHESIS [J].
KING, BH ;
LISTON, EH .
BIOLOGICAL PSYCHIATRY, 1990, 27 (01) :76-94